Oct 27, 2022 / 12:00PM GMT
Operator
Ladies and gentlemen, welcome to the Xvivo Group Interim Report Q3 2022. (Operator Instructions)
Now I will now hand over to Christoffer Rosenblad, acting CEO. Please go ahead.
Christoffer Rosenblad - Xvivo Perfusion AB(publ)-Acting CEO
Thank you so much, and welcome to you all to Xvivo's Earnings Call for the Third Quarter of 2022. I move over to Slide #2 on the slide deck. Today's presenters are myself, Christoffer Rosenblad, acting CEO for (inaudible); and Kristoffer Nordstrom, CFO, DuMet before. As you all know, our CEO, Doug Anderson passed away a month ago, and I assumed the role as active here immediately. Our thoughts are with Doug's family. So the ones on the call that don't know me, this is actually my 34th quarter earnings call, but my first as acting CEO. I worked for (inaudible) for 10 years, where as CFO; and 2 years as COO and Business Development Director. (inaudible) for North America during 2015 to 2017 and are been serving as deputy CEO since 2017 until now.
Let's move over to Slide #3 in
Q3 2022 Xvivo Perfusion AB Earnings Call Transcript
Oct 27, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers